valproic acid has been researched along with morphine in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (42.50) | 18.7374 |
1990's | 2 (5.00) | 18.2507 |
2000's | 11 (27.50) | 29.6817 |
2010's | 9 (22.50) | 24.3611 |
2020's | 1 (2.50) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Topliss, JG; Yoshida, F | 1 |
Chang, TK; Ensom, MH; Kiang, TK | 1 |
Jolivette, LJ; Ward, KW | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bruinvels, J; de Boer, T; Metselaar, HJ | 1 |
Bulaev, VM; Ostrovskaia, RU | 1 |
Breimer, DD; de Boer, AG; van Hoogdalem, E | 1 |
Bossut, D; Frenk, H; Mayer, DJ | 1 |
Aley, KO; Kulkarni, SK | 1 |
Andreev, BV; Ignatov, IuD | 1 |
Hillen, FC; Van der Laan, JW; Van Veenendaal, W; Voorthuis, P; Weick, G | 1 |
Chapman, AG | 1 |
van Bleek, G; van der Laan, JW; Weick, G | 1 |
Hancock, S; Picker, M; Poling, A; Wallace, S | 1 |
Hillen, FC; van der Laan, JW; Weick, G | 1 |
Bulayev, VM; Ostrovskaya, RU; Zakusov, VV | 1 |
Bruinvels, J; van der Laan, JW | 1 |
Contreras, E; Tamayo, L | 1 |
van der Laan, JW | 1 |
Katz, RJ; Schmaltz, K | 1 |
Bruinvels, J; Cools, AR; van der Laan, JW | 1 |
Gregus, Z; Klaassen, CD; Thompson, TN; Watkins, JB | 1 |
Hirohashi, M; Kitano, Y; Nomura, M; Takasuna, K; Usui, C | 1 |
Li, JX; Liang, JH; Zhang, Q | 1 |
Mu, P; Yu, LC | 1 |
Aoe, T; Dobashi, T; Jin, H; Nishino, T; Tanabe, S | 1 |
Jing, L; Lawrence, AJ; Li, YL; Liang, JH; Liu, Q; Luo, J; Qin, WJ; Wang, YT; Zhang, M | 1 |
Bhatt, J; Daugé, V; Estevez, L; Giros, B; Morel, LJ; Naudon, L; Tesone-Coelho, C; Zwiller, J | 1 |
El-Hage, N; Hauser, KF; Knapp, PE; Masvekar, RR | 1 |
Araki, K; Matsushita, Y; Mukae, T; Uchida, H; Ueda, H | 1 |
Calcagno, P; Finn, DP; Hughes, EM; Kelly, JP; Roche, M; Sanchez, C; Smith, K | 1 |
5 review(s) available for valproic acid and morphine
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacokinetics of rectal drug administration, Part I. General considerations and clinical applications of centrally acting drugs.
Topics: Administration, Rectal; Antiemetics; Atropine; Carbamazepine; Clonazepam; Delayed-Action Preparations; Diazepam; Flunitrazepam; Humans; Hydromorphone; Intestinal Absorption; Methadone; Methohexital; Midazolam; Morphine; Pharmacokinetics; Phenobarbital; Valproic Acid | 1991 |
Valproate and myoclonus.
Topics: 5-Hydroxytryptophan; Amino Acids; Animals; Aspartic Acid; Clonazepam; DDT; Disease Models, Animal; Flurazepam; gamma-Aminobutyric Acid; Glycine; Isoxazoles; Light; Morphine; Muscimol; Myoclonus; Serotonin; Urea; Valproic Acid | 1986 |
35 other study(ies) available for valproic acid and morphine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Suppression of GABA-induced abstinence behaviour in naive rats by morphine and bicuculline.
Topics: Aminobutyrates; Animals; Behavior, Animal; Bicuculline; Dose-Response Relationship, Drug; GABA Antagonists; gamma-Aminobutyric Acid; Humans; Isoquinolines; Male; Morphine; Motor Activity; Naloxone; Rats; Receptors, Drug; Receptors, Opioid; Substance Withdrawal Syndrome; Valerates; Valproic Acid | 1977 |
[Effect of GABA-ergic substances on the analgesic effect of morphine in rats].
Topics: Analgesia; Animals; Bicuculline; Dose-Response Relationship, Drug; Drug Interactions; gamma-Aminobutyric Acid; Male; Morphine; Rats; Receptors, Drug; Thiosemicarbazones; Time Factors; Valproic Acid; Vocalization, Animal | 1979 |
Is substance P a primary afferent neurotransmitter for nociceptive input? III. Valproic acid and chlordiazepoxide decrease behaviors elicited by intrathecal injection of substance P and excitatory compounds.
Topics: Animals; Anticonvulsants; Chlordiazepoxide; Injections, Spinal; Kainic Acid; Male; Morphine; Nociceptors; Pain; Rats; Rats, Inbred Strains; Spinal Cord; Strychnine; Substance P; Valproic Acid | 1988 |
GABAergic agents-induced antinociceptive effect in mice.
Topics: Analgesics; Animals; Baclofen; Bicuculline; Female; gamma-Aminobutyric Acid; Male; Mice; Morphine; Muscimol; Pain; Picrotoxin; Rats; Rats, Inbred Strains; Reaction Time; Sensory Thresholds; Valproic Acid | 1989 |
[Role of opioid and adrenergic mechanisms in the analgesic action of GABA-positive drugs].
Topics: 4-Aminobutyrate Transaminase; Analgesics; Animals; Baclofen; Clonidine; Drug Tolerance; Female; Male; Morphine; Nociceptors; Pain Measurement; Rats; Receptors, Adrenergic, alpha; Receptors, GABA-A; Valproic Acid | 1988 |
The effects of centrally acting adrenergic agonists on temperature and on explorative and motor behaviour. Relation with effects on quasi-morphine withdrawal behaviour.
Topics: Adrenergic alpha-Agonists; Animals; Body Temperature; Exploratory Behavior; Humans; Male; Morphine; Motor Activity; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Valproic Acid | 1985 |
Effects of inhibitors of GABA-transaminase on hole-board exploration and on temperature. Relation with effects on quasi-morphine abstinence behaviour induced by sodium dipropylacetate.
Topics: 4-Aminobutyrate Transaminase; Aminooxyacetic Acid; Animals; Body Temperature; Ethanolamines; Exploratory Behavior; Glutamate Decarboxylase; Male; Morphine; Rats; Substance Withdrawal Syndrome; Valproic Acid | 1985 |
Discriminative stimulus properties of valproic acid in the pigeon.
Topics: Animals; Anticonvulsants; Columbidae; Dextroamphetamine; Discrimination Learning; Generalization, Psychological; Imipramine; Morphine; Pentylenetetrazole; Valproic Acid | 1985 |
Dipropylacetate-induced quasi-morphine abstinence behaviour in the rat: suppression by alpha 2-adrenoceptor stimulation.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Clonidine; Humans; Male; Morphine; Motor Activity; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Valproic Acid | 1983 |
GABA-opiates interactions in the activity of analgesics.
Topics: Aminooxyacetic Acid; Analgesics, Opioid; Animals; Bicuculline; Cyclic GMP; Drug Interactions; gamma-Aminobutyric Acid; Male; Morphine; Rats; Receptors, Cell Surface; Receptors, GABA-A; Receptors, Opioid; Structure-Activity Relationship; Valproic Acid | 1983 |
Dipropylacetate-induced quasi-morphine abstinence behaviour in the rat: involvement of amygdaloid and thalamic structures.
Topics: Amygdala; Animals; Bicuculline; Caudate Nucleus; Hippocampus; Humans; Male; Morphine; Rats; Receptors, Cell Surface; Receptors, GABA-A; Receptors, Opioid; Substance Withdrawal Syndrome; Substantia Nigra; Thalamic Nuclei; Valproic Acid | 1981 |
A dual action of valproic acid upon morphine analgesia and morphine withdrawal.
Topics: Analgesia; Animals; Brain Chemistry; Female; gamma-Aminobutyric Acid; Humans; Mice; Morphine; Naloxone; Substance Withdrawal Syndrome; Valproic Acid | 1983 |
Quasi-morphine withdrawal behaviour: indication for a specific involvement of the GABA-ergic nerve terminal compartment.
Topics: Animals; gamma-Aminobutyric Acid; Humans; Male; Morphine; Motor Activity; Neurons; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substance Withdrawal Syndrome; Valproic Acid | 1983 |
Behavioral interactions between opiate and antiepileptic drugs in the mouse.
Topics: Animals; Anticonvulsants; Behavior, Animal; Drug Interactions; Enkephalins; Male; Mice; Morphine; Narcotics; Taurine; Time Factors; Trimethadione; Valproic Acid | 1981 |
Dipropylacetate-induced quasi-morphine abstinence behaviour in the rat: participation of the locus coeruleus system.
Topics: Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Disease Models, Animal; Humans; Locus Coeruleus; Male; Morphine; Movement Disorders; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Valproic Acid | 1982 |
Induction studies on the functional heterogeneity of rat liver UDP-glucuronosyltransferases.
Topics: Animals; Chloramphenicol; Enzyme Induction; Glucuronates; Glucuronic Acid; Glucuronosyltransferase; In Vitro Techniques; Liver; Male; Methylcholanthrene; Morphine; Polychlorinated Dibenzodioxins; Rats; Rats, Inbred Strains; Valproic Acid | 1982 |
Increasing-current electroshock seizure test: a new method for assessment of anti- and pro-convulsant activities of drugs in mice.
Topics: Analgesics, Opioid; Animals; Anticonvulsants; Carbamazepine; Convulsants; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation; Drug Interactions; Ear; Electrodes; Electroshock; Ethosuximide; Injections, Intravenous; Male; Mice; Morphine; Phenobarbital; Phenytoin; Seizures; Valproic Acid | 1996 |
Valproate prevents the induction, but not the expression of morphine sensitization in mice.
Topics: Analysis of Variance; Animals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; GABA Agents; Male; Mice; Morphine; Motor Activity; Narcotics; Stereotyped Behavior; Time Factors; Valproic Acid | 2004 |
Valproic acid sodium inhibits the morphine-induced conditioned place preference in the central nervous system of rats.
Topics: Animals; Behavior, Animal; Brain; Conditioning, Classical; GABA Agents; Injections, Intraventricular; Male; Morphine; Morphine Dependence; Narcotics; Rats; Rats, Wistar; Valproic Acid | 2007 |
Valproate attenuates the development of morphine antinociceptive tolerance.
Topics: Analgesics; Animals; Drug Tolerance; GABA Agents; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hot Temperature; Male; Mice; Mice, Inbred C57BL; Morphine; Morphine Dependence; Pain Measurement; Pain Threshold; Valproic Acid | 2010 |
Effect of the histone deacetylase inhibitors on behavioural sensitization to a single morphine exposure in mice.
Topics: Acetylation; Analgesics, Opioid; Animals; Behavior, Animal; Blotting, Western; Histone Deacetylase Inhibitors; Histones; Male; Mice; Mice, Inbred C57BL; Morphine; Motor Activity; Valproic Acid | 2011 |
Vulnerability to opiate intake in maternally deprived rats: implication of MeCP2 and of histone acetylation.
Topics: Acetylation; Analgesics, Opioid; Animals; Behavior, Animal; Epigenesis, Genetic; Gene-Environment Interaction; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Maternal Deprivation; Methyl-CpG-Binding Protein 2; Morphine; Nucleus Accumbens; Opioid-Related Disorders; Rats; Valproic Acid | 2015 |
GSK3β-activation is a point of convergence for HIV-1 and opiate-mediated interactive neurotoxicity.
Topics: Animals; Cell Line, Tumor; Cells, Cultured; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HIV-1; Humans; Mice; Morphine; Neurons; Valproic Acid | 2015 |
Histone deacetylase inhibitors relieve morphine resistance in neuropathic pain after peripheral nerve injury.
Topics: Acetylation; Analgesia; Analgesics; Animals; Down-Regulation; Drug Resistance; Ganglia, Spinal; Gene Expression; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Hydroxamic Acids; Male; Mice, Inbred C57BL; Morphine; Neuralgia; Peripheral Nerve Injuries; Receptors, Opioid, mu; Valproic Acid | 2015 |
Mu-opioid receptor agonism differentially alters social behaviour and immediate early gene expression in male adolescent rats prenatally exposed to valproic acid versus controls.
Topics: Analgesics, Opioid; Animals; Anticonvulsants; Female; Gene Expression; Genes, fos; Genes, Immediate-Early; Hippocampus; Male; Morphine; Pregnancy; Prenatal Exposure Delayed Effects; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Social Behavior; Valproic Acid | 2021 |